FindTrial
Sign In

Significance of p21 expression in oral squamous cell carcinoma

Associations between clinicopathological factors and p21 expression in oral squamous cell carcinoma: A meta-analysis - p21 expression in oral squamous cell carcinoma: A meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000052042
Enrollment
Unknown
Registered
2023-10-01
Start date
2023-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral squamous cell carcinoma

Interventions

None listed

Sponsors

Department of Medical Laboratory Sciences, School of Allied Health Sciences Kitasato University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PubMed and Web of Science were searched to identify papers. We also searched the reference lists of the included papers. The following search keywords were used: oral squamous cell carcinoma, p21, and clinicopathological.

Exclusion criteria

Exclusion criteria: We excluded studies published in languages other than Japanese or English as well as those that used cultured cells or animal experiments, case reports, review articles, and papers lacking data on relationships between clinicopathological factors and p21 expression.

Design outcomes

Primary

MeasureTime frame
We will performe a meta-analysis to evaluate the associations between clinicopathological factors and the p21 expression in OSCC.—

Countries

Japan,Asia(except Japan),North America,South America,Australia,Europe,Africa

Contacts

Public ContactHiroyuki Takahashi

Department of Medical Laboratory Sciences, School of Allied Health Sciences Kitasato University Pathology

hitakaha@med.kitasato-u.ac.jp042-778-8300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026